REPORTING OF TRANSACTIONS IN ORPHAZYME'S SHARES MADE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

Copenhagen, Denmark, March 4, 2019 – Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), hereby notifies receipt of information of the following transactions in Orphazyme’s shares by persons discharging managerial responsibilities in Orphazyme in connection with the vesting of Matching Shares:

1 Details of the Reporting Person / Closely Associated Person

a) Name

Anders Hinsby

2 Reason for the notification

a) Position/status

Chief Executive Officer

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Vesting of Matching Shares

c) Price(s) and volume(s)

Price (s) DKK 1.00
Volume(s) 5,000

d) Aggregated information

- Aggregated volume

- Price

e) Date of the transaction

March 4, 2019

f) Place of the transaction

Outside a trading venue

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Anders Vadsholt

2 Reason for the notification

a) Position/status

Chief Financial Officer

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Vesting of Matching Shares

c) Price(s) and volume(s)

Price (s) DKK 1.00
Volume(s) 4,000

d) Aggregated information

- Aggregated volume

- Price

e) Date of the transaction

March 4, 2019

f) Place of the transaction

Outside a trading venue

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Thomas Kirkegaard Jensen

2 Reason for the notification

a) Position/status

Chief Scientific Officer

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Vesting of Matching Shares

c) Price(s) and volume(s)

Price (s) DKK 1.00

Volume(s) 4,000

d)

Aggregated information

- Aggregated volume

- Price

e) Date of the transaction

March 4, 2019

f) Place of the transaction

Outside a trading venue

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Thomas Blaettler

2 Reason for the notification

a) Position/status

Chief Medical Officer

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Vesting of Matching Shares

c) Price(s) and volume(s)

Price (s) DKK 1.00

Volume(s) 1,875

d) Aggregated information

- Aggregated volume

- Price

e) Date of the transaction

March 4, 2019

f) Place of the transaction

Outside a trading venue

 

1 Details of the Reporting Person / Closely Associated Person

a) Name

Paul Merrigan

2 Reason for the notification

a) Position/status

Chief Commercial Officer

b) Initial notification/Amendment

Initial notification

3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

Orphazyme A/S

b) LEI code

54930025OZD2GGSQ7L42

4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of instrument and identification code

Shares

ISIN DK0060910917

b) Nature of the transaction

Vesting of Matching Shares

c) Price(s) and volume(s)

Price (s) DKK 1.00
Volume(s) 4,300

d) Aggregated information

- Aggregated volume

- Price

e) Date of the transaction

March 4, 2019

f) Place of the transaction

Outside a trading venue